In February 2021 Tavistock helped make history as PR advisor to MGC Pharmaceuticals, the first medicinal cannabis company to IPO on the London Stock Exchange, which raised £6.5m in the process.

MGC Pharma is a European based bio-pharma company developing and supplying affordable standardised phyto-medicines to patients globally. It’s research and treatments are focused on using phytomedicines in three core areas: Neurology, Oncology, and Autoimmune diseases – including ArtemiC™ for treatment of Covid-19 infected patients.

Other Case Studies

Financial & Corporate PR: Milk & More

READ MORE

Financial and Corporate PR: Zegona Communications

READ MORE

Financial PR: FTSE 100 Avast plc

READ MORE

Financial and Corporate PR: Vodafone Group Plc

READ MORE

Corporate Campaign: Rolls-Royce

READ MORE

Dual Listing: Resolute Mining

READ MORE

M&A: Gemfields

READ MORE

IPO: Ten Lifestyle

READ MORE

M&A: Dee Valley

READ MORE